Isoniazid-monoresistant tuberculosis in France: Risk factors, treatment outcomes and adverse events.
Bachir M, Guglielmetti L, Tunesi S, Billard-Pomares T, Chiesi S, Jaffré J, Langris H, Pourcher V, Schramm F, Lemaître N, Robert J; Isoniazid Resistance Group.
Bachir M, et al. Among authors: chiesi s.
Int J Infect Dis. 2021 Jun;107:86-91. doi: 10.1016/j.ijid.2021.03.093. Epub 2021 Apr 3.
Int J Infect Dis. 2021.
PMID: 33823278
Free article.